COVID could evolve to become more severe JN.1's parent can infect lung cells more efficiently, a mutation that's different from the "milder" Omicron Salon · Jan 12, 2024
Why hasn't the WHO assigned a Greek letter to JN.1 "Pirola"? How it decides when to name COVID-19 variants In an exclusive interview with Fortune, the WHO's COVID-19 lead said the organization is ready to assign a new Greek letter on a moment’s notice, but is holding out for a variant that's "truly different." Not all experts agree with the approach. Fortune · Jan 4, 2024
JN.1, the WHO’s newest ‘variant of interest,’ has spiked COVID wastewater levels to all-time highs in some countries. What you need to know about the ‘Pirola’ offshoot How dangerous is JN.1, how likely are you to get it, and could it derail your holiday plans? Here’s what you need to know, according to the experts Fortune spoke with. Fortune · Dec 20, 2023
‘Pirola' BA.2.86 may not be a 'black swan' event like Omicron, experts say. It's what could spawn from the COVID variant that has them worried We can, perhaps, breathe a collective sigh of relief—for the moment. But it’s far from time to let our guard down, experts tell Fortune. Fortune · Sep 1, 2023
With ‘Eris’ rising and now ‘Fornax,’ when are COVID cases likely to peak again? A look at what may lie ahead for fall and winter Expect peaks this fall and winter not as much as a high wall of cases, experts say. Fortune · Aug 11, 2023
WHO designates ‘Eris' and related COVID strains as variants of interest as infections and hospitalizations tick upward Plus, a look ahead at what’s likely to come this fall and winter: ‘My best guess is we're heading back up to a high baseline’ of cases, one expert tells Fortune. Fortune · Aug 8, 2023
Is the U.S. headed for another 'tripledemic' this fall? As COVID cases and hospitalizations rise, experts warn it could happen again Should the country brace itself for wave upon wave of respiratory illness again this fall? It’s too soon to say—but "an ounce of prevention is worth a pound of cure," experts say. Fortune · Aug 4, 2023
‘Arcturus,’ a COVID variant sweeping India, is now in the U.S., the CDC says—and it's coming in hot. What it means for the future of the pandemic XBB.1.16, dubbed "Arcturus" by variant trackers, is estimated to be behind 7% of COVID cases in the country this week. Fortune · Apr 14, 2023
‘Arcturus,’ a highly transmissible COVID variant eyed by the WHO, appears to have a new symptom. Here's what you need to know XBB.1.16 may not be just another run-of-the-mill Omicron, according to a prominent pediatrician in India. Fortune · Apr 11, 2023
'Everyone is kind of tired and has given up' on COVID. But this new variant is 'one to watch,' the WHO says Here’s what we know so far about the latest variant to raise eyebrows—and the first to do so in several months. Fortune · Mar 31, 2023
The ‘Gryphon’ family of COVID variants is off the leash and spreading globally—but their bark may be a lot worse than their bite A new study breaks down the quickly spreading variants’ common symptoms among 85 patients. Only three died. Fortune · Jan 12, 2023
Meet the biology professor who named the surging 'Kraken' COVID variant. He has more to help make sense of Omicron's 'alphabet soup' When Ryan Gregory noticed the name "Centaurus" pick up steam on Twitter, he was intrigued. Fortune · Jan 5, 2023